LIPELLA PHARMACEUTICALS INC. (LIPO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2024, LIPELLA PHARMACEUTICALS INC. reported revenue of $536.4K, up 19.3% from the prior year. The company ran a net loss, with a net margin of -935.2%. It held $2.67M in total assets against $754.4K in total liabilities.
Key ratios (FY2024)
-947.2%
Operating margin
-935.2%
Net margin
-261.3%
Return on equity
+19.3%
Revenue growth (YoY)
| Metric (FY) | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $536.4K | $449.6K | $184.2K | $259.3K | — |
| Operating Income | -$5.08M | -$4.75M | -$2.59M | -$1.92M | — |
| Net Income | -$5.02M | -$4.62M | -$2.60M | -$1.87M | — |
| EPS (Diluted) | $-4.79 | $-6.16 | $-0.64 | $-0.55 | — |
| Total Assets | $2.67M | $3.58M | $5.95M | $2.01M | — |
| Total Liabilities | $754.4K | $432.7K | $1.27M | $589.3K | — |
| Shareholders' Equity | $1.92M | $3.14M | $4.68M | $1.42M | $463.3K |
| Cash & Equivalents | $2.18M | $3.29M | $5.12M | $1.41M | — |
| Operating Cash Flow | -$3.95M | -$3.15M | -$1.83M | -$989.3K | — |
| Capital Expenditures | — | $14.4K | — | — | — |
| Shares Outstanding | 1.21M | 756.7K | 5.74M | 3.87M | — |